Abstract: The present invention relates to processes for preparing transformed plant cells or organisms by transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect for said population, with at least one nucleic acid sequence to be inserted in combination with at least one compound, preferably a DNA construct, capable of reducing the expression, amount, activity and/or function of the marker protein, with the transformed plant cells having a growth advantage over nontransformed cells, due to the action of said compound.

Abstract: The present invention relates to processes for preparing transformed plant cells or organisms by transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect for the population, with at least one nucleic acid sequence to be inserted in combination with at least one compound, preferably a DNA construct, capable of reducing the expression, amount, activity and/or function of the marker protein, with the transformed plant cells having a growth advantage over nontransformed cells, due to the action of the compound.

Abstract: The present invention relates to a process for producing vitamin E by growing organisms, in particular plants, which have an increased tyrosine aminotransferase activity in comparison with the wild type, and to the genetically modified organisms, in particular plants, themselves.

Abstract: The present invention relates to a process for the production of fine chemicals, in particular vitamin E, vitamin K and/or ubiquinone by culturing organisms, in particular plants, whose shikimate pathway is genetically modified over that of the wild type, and to the transgenic organisms themselves.

Abstract: The present invention relates to processes for preparing transformed plant cells or organisms by transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect for said population, with at least one nucleic acid sequence to be inserted in combination with at least one compound, preferably a DNA construct, capable of reducing the expression, amount, activity and/or function of the marker protein, with the transformed plant cells having a growth advantage over nontransformed cells, due to the action of said compound.

Abstract: The present invention relates to a process for the production of fine chemicals, in particular vitamin E, vitamin K and/or ubiquinone by culturing organisms, in particular plants, whose shikimate pathway is genetically modified over that of the wild type, and to the transgenic organisms themselves.

Abstract: The present invention relates to the use of DNA sequences of plant origin encoding a polypeptide with phosphoribosyl-pyrophosphate synthetase 1 (E.C. 2.7.6.1) activity for the preparation of a test system for identifying phosphoribosyl-pyrophosphate synthetase 1 inhibitors. It was shown for the first time, using antisense technology, that phosphoribosyl-pyrophosphate synthetase 1 is a herbicidal [sic] target.

Abstract: The invention relates to a method for producing vitamin E by cultivating organisms, especially plants, which have an increased tyrosine aminotransferase activity in relation to the wild type. The invention also relates to the genetically modified organisms, especially plants themselves.

Abstract: Isolated nucleic acid molecules, designated TCMRP nucleic acid molecules, which encode novel TCMRPs from e.g. Phycomitrella patens are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TCMRP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated TCMRPs, mutated TCMRPs, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells, organisms or plants based on genetic engineering of TCMRP genes in these organisms.

Abstract: The invention relates to nucleic acid sequences encoding a protein with homogentisate phytyltransferase activity, to the use of the nucleic acids for generating transgenic organisms such as, for example, transgenic plants with an elevated tocopherol and tocotrienol content, to a method of generating plants with an elevated tocopherol and/or tocotrienol content, and to the transgenic plants themselves.